OHRP - OHR Pharmaceutical, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 513.55M
Enterprise Value 39.74M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.79
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.80

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 30, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-32.05%
Return on Equity (ttm)-53.70%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -12.15M
Net Income Avi to Common (ttm)-12.13M
Diluted EPS (ttm)-0.22
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.44M
Total Cash Per Share (mrq)0.08
Total Debt (mrq)181.55k
Total Debt/Equity (mrq)1.06
Current Ratio (mrq)5.46
Book Value Per Share (mrq)0.30

Cash Flow Statement

Operating Cash Flow (ttm)-14.17M
Levered Free Cash Flow (ttm)-10.85M

Trading Information

Stock Price History

Beta (3Y Monthly) -1.04
52-Week Change 3-58.00%
S&P500 52-Week Change 37.73%
52 Week High 32.18
52 Week Low 30.15
50-Day Moving Average 30.21
200-Day Moving Average 30.21

Share Statistics

Avg Vol (3 month) 3959.62k
Avg Vol (10 day) 32.12M
Shares Outstanding 556.47M
Float 52.17M
% Held by Insiders 14.43%
% Held by Institutions 114.74%
Shares Short (Sep 28, 2018) 41.15M
Short Ratio (Sep 28, 2018) 41.55
Short % of Float (Sep 28, 2018) 42.23%
Short % of Shares Outstanding (Sep 28, 2018) 42.03%
Shares Short (prior month Aug 31, 2018) 4951.11k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/3
Last Split Date 3Jun 3, 2013